Finding funding in biotechnology - Keeping the companies alive
被引:0
|
作者:
Dibner, MD
论文数: 0引用数: 0
h-index: 0
机构:BioAbil LLC, Res Triangle Pk, NC 27709 USA
Dibner, MD
Howell, M
论文数: 0引用数: 0
h-index: 0
机构:BioAbil LLC, Res Triangle Pk, NC 27709 USA
Howell, M
机构:
[1] BioAbil LLC, Res Triangle Pk, NC 27709 USA
[2] Univ N Carolina, Neurobiol Curriculum, Chapel Hill, NC USA
来源:
BIOPHARM-THE APPLIED TECHNOLOGIES OF BIOPHARMACEUTICAL DEVELOPMENT
|
2002年
/
15卷
/
06期
关键词:
D O I:
暂无
中图分类号:
Q81 [生物工程学(生物技术)];
Q93 [微生物学];
学科分类号:
071005 ;
0836 ;
090102 ;
100705 ;
摘要:
Biotechnology appears to be "the place to be" for venture capitalists, capturing the largest percentage increase in investment for 2001. The value of biotech companies has risen sharply, and many economists are predicting an end to the IPO drought.
机构:
Royal Bank Canada, Life Sci & Hlth Care, Knowledge Based Ind, Ottawa, ON, CanadaRoyal Bank Canada, Life Sci & Hlth Care, Knowledge Based Ind, Ottawa, ON, Canada